To analyze the clinical effect of thoracoscopic surgery on early lung cancer
Objective To observe the clinical effect of thoracoscopic surgery on early lung cancer. Methods A total of 40 patients with early lung cancer admitted to our hospital from March 2020 to March 2022 were selected as subjects of this study. The patients were divided into control group (20 cases: traditional thoracoscopic surgery) and experimental group (20 cases: thoracoscopic surgery) according to whether they had undergone thoracoscopic surgery, and the therapeutic effects of the two groups were compared. Results Experimental group 24 h physiological stress index [cortisol was (525.64±38.64) nmol/L, (112.43±15.64) ng/L, interleukin-6 was (82.43±10.58) ng/L, C-reactive protein was (88.98±10.54) mg/L,] , tumor factor index [CA125 was (80) 53±16.76) kU/L, CEA was (7.23±0.32) μg/L, NSE was (16.76±1.32) U/mL, CA19-9 was (68.53±2.54) kU/L] , clinical indexes and postoperative complication rate (20.00％) were better than the control group. The difference was statistically significant (P＜0.05). Conclusion Thoracoscopic surgery is better than traditional thoracotomy for early lung cancer patients.
traditional thoracotomytotal thoracoscopic surgeryearly stage lung cancer
周恒、Jia Zheng-yan
展开 >
青县人民医院肿瘤普外科,河北 沧州 062650
Department of General Surgery, Qingxian People's Hospital, Cangzhou 062650, China
万方数据
